ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 135 filers reported holding ANI PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,183,009 | +17.6% | 123,717 | +9.0% | 0.00% | +100.0% |
| Q2 2023 | $6,108,790 | +40.5% | 113,483 | +3.6% | 0.00% | 0.0% |
| Q1 2023 | $4,348,902 | -5.3% | 109,489 | -4.0% | 0.00% | 0.0% |
| Q4 2022 | $4,590,122 | +18.4% | 114,097 | -5.4% | 0.00% | 0.0% |
| Q3 2022 | $3,876,000 | +7.8% | 120,634 | -0.5% | 0.00% | 0.0% |
| Q2 2022 | $3,596,000 | +3.9% | 121,184 | -1.5% | 0.00% | 0.0% |
| Q1 2022 | $3,460,000 | -46.9% | 123,086 | -12.9% | 0.00% | 0.0% |
| Q4 2021 | $6,515,000 | +107.0% | 141,379 | +47.4% | 0.00% | 0.0% |
| Q3 2021 | $3,147,000 | -4.3% | 95,902 | +2.2% | 0.00% | 0.0% |
| Q2 2021 | $3,290,000 | -9.8% | 93,850 | -7.0% | 0.00% | 0.0% |
| Q1 2021 | $3,646,000 | +21.0% | 100,879 | -2.8% | 0.00% | 0.0% |
| Q4 2020 | $3,012,000 | -2.2% | 103,736 | -5.0% | 0.00% | 0.0% |
| Q3 2020 | $3,079,000 | -9.8% | 109,161 | +3.5% | 0.00% | 0.0% |
| Q2 2020 | $3,412,000 | -20.0% | 105,519 | +0.8% | 0.00% | 0.0% |
| Q1 2020 | $4,265,000 | -36.3% | 104,669 | -3.6% | 0.00% | -50.0% |
| Q4 2019 | $6,699,000 | -15.6% | 108,609 | -0.3% | 0.00% | 0.0% |
| Q3 2019 | $7,939,000 | -11.6% | 108,934 | -0.3% | 0.00% | 0.0% |
| Q2 2019 | $8,982,000 | +21.5% | 109,263 | +4.2% | 0.00% | 0.0% |
| Q1 2019 | $7,393,000 | +22.0% | 104,821 | -22.1% | 0.00% | 0.0% |
| Q4 2018 | $6,059,000 | -20.1% | 134,589 | +0.4% | 0.00% | 0.0% |
| Q3 2018 | $7,583,000 | -16.3% | 134,115 | -1.1% | 0.00% | 0.0% |
| Q2 2018 | $9,056,000 | +20.3% | 135,557 | +4.8% | 0.00% | 0.0% |
| Q1 2018 | $7,528,000 | -40.5% | 129,295 | -34.2% | 0.00% | -33.3% |
| Q4 2017 | $12,660,000 | +53.7% | 196,442 | +25.2% | 0.00% | +50.0% |
| Q3 2017 | $8,235,000 | +39.4% | 156,865 | +24.3% | 0.00% | 0.0% |
| Q2 2017 | $5,908,000 | -16.3% | 126,233 | -11.4% | 0.00% | 0.0% |
| Q1 2017 | $7,056,000 | -28.7% | 142,514 | -12.8% | 0.00% | -33.3% |
| Q4 2016 | $9,902,000 | -22.9% | 163,354 | -15.6% | 0.00% | -25.0% |
| Q3 2016 | $12,842,000 | +92.0% | 193,535 | +61.5% | 0.00% | +100.0% |
| Q2 2016 | $6,687,000 | +58.6% | 119,807 | -4.3% | 0.00% | +100.0% |
| Q1 2016 | $4,216,000 | -19.8% | 125,223 | +7.5% | 0.00% | -50.0% |
| Q4 2015 | $5,256,000 | +27.8% | 116,493 | +12.0% | 0.00% | +100.0% |
| Q3 2015 | $4,112,000 | -18.2% | 104,053 | +28.5% | 0.00% | 0.0% |
| Q2 2015 | $5,024,000 | +17.4% | 80,972 | +18.3% | 0.00% | 0.0% |
| Q1 2015 | $4,281,000 | +67.4% | 68,460 | +51.0% | 0.00% | 0.0% |
| Q4 2014 | $2,557,000 | +196.3% | 45,340 | +48.7% | 0.00% | – |
| Q3 2014 | $863,000 | -54.4% | 30,492 | -44.5% | 0.00% | – |
| Q2 2014 | $1,892,000 | – | 54,978 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 200,000 | $13,270,000 | 21.02% |
| Healthcare Value Capital, LLC | 50,000 | $3,318,000 | 5.26% |
| Consonance Capital Management LP | 653,258 | $43,344,000 | 4.17% |
| 1492 Capital Management LLC | 34,500 | $2,289,000 | 1.87% |
| JW Asset Management, LLC | 29,722 | $1,972,000 | 1.36% |
| FRANKLIN STREET ADVISORS INC /NC | 29,000 | $1,924,000 | 0.35% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 55,705 | $3,696,000 | 0.27% |
| Ativo Capital Management LLC | 15,805 | $1,049,000 | 0.24% |
| DIKER MANAGEMENT LLC | 9,810 | $651,000 | 0.23% |
| CASTLEARK MANAGEMENT LLC | 100,615 | $6,676,000 | 0.20% |